Feng Lei, Cheah Irwin Kee-Mun, Ng Maisie Mei-Xi, Li Jialiang, Chan Sue Mei, Lim Su Lin, Mahendran Rathi, Kua Ee-Heok, Halliwell Barry
Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
J Alzheimers Dis. 2019;68(1):197-203. doi: 10.3233/JAD-180959.
We examined the cross-sectional association between mushroom intake and mild cognitive impairment (MCI) using data from 663 participants aged 60 and above from the Diet and Healthy Aging (DaHA) study in Singapore. Compared with participants who consumed mushrooms less than once per week, participants who consumed mushrooms >2 portions per week had reduced odds of having MCI (odds ratio = 0.43, 95% CI 0.23-0.78, p = 0.006) and this association was independent of age, gender, education, cigarette smoking, alcohol consumption, hypertension, diabetes, heart disease, stroke, physical activities, and social activities. Our cross-sectional data support the potential role of mushrooms and their bioactive compounds in delaying neurodegeneration.
我们利用新加坡饮食与健康老龄化(DaHA)研究中663名60岁及以上参与者的数据,研究了蘑菇摄入量与轻度认知障碍(MCI)之间的横断面关联。与每周食用蘑菇少于一次的参与者相比,每周食用蘑菇超过2份的参与者患MCI的几率降低(优势比=0.43,95%置信区间0.23-0.78,p=0.006),且这种关联独立于年龄、性别、教育程度、吸烟、饮酒、高血压、糖尿病、心脏病、中风、体育活动和社交活动。我们的横断面数据支持蘑菇及其生物活性化合物在延缓神经退行性变方面的潜在作用。